Article: Nicotinamide Riboside Supplementation Reduces Inflammation in Heart Failure Patients: Clinical Findings

Aug 13, 2020 Cardiovascular Disease Cardiovascular Health Clinical Inflammation

Nicotinamide Riboside Supplementation Reduces Inflammation in Heart Failure Patients: Clinical Findings

Objectives

To investigate the mechanistic link between mitochondrial dysfunction and inflammatory activation in peripheral blood mononuclear cells (PBMCs), and the potential anti-inflammatory effect of boosting NAD+ levels.

Journal

Journal of Clinical Investigation

Key Outcomes

NR supplementation increased whole blood NAD+ levels and mitochondrial respiration rate of the heart failure patients' PBMCs.
NR reduced the production and gene expression of proinflammatory cytokines.
The systemic inflammation in heart failure patients was causally linked to mitochondrial function of the PBMCs.

Duration

5-9 days

Dose

2000 mg

Study Design

Ex vivo and pilot clinical study in 5 Stage D heart failure patients

See Published Study

Mitochondrial Health

A New Bioluminescent Probe to Monitor Mitochondrial Health Over Time: Preclinical Findings

SynopsisMitochondrial membrane potential (ΔΨm) is a key indicator of mitochondrial health and is involved in diseases like diabetes, cancer, Alzheimer’s, and Parkinson’s. This study introduces a ne...

Neurological Health

Fixing Imbalanced NAD Metabolism Reduces Effects of Telomere Dysfunction: Preclinical Findings

Synopsis Short telomeres cause diseases like dyskeratosis congenita (DC), which lack effective treatments. This study found that cells from DC patients and telomerase-deficient mice have low NAD+ ...